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Background: Approximately 8% of male patients presenting with primary mediastinal 
germ cell tumors (GCTs) have Klinefelter syndrome (KS), while patients diagnosed 
with retroperitoneal GCTs also exhibit a range of chromosomal abnormalities. The 
exact mechanism underlying the development of GCTs in Klinefelter syndrome is un-
known, but KS frequently goes underdiagnosed as a result of its varied symptoms and 
a low general awareness of this condition. Thus, the Children’s Oncology Group rec-
ommends screening of Klinefelter syndrome in pediatric and adolescent male sub-
jects who present with GCTs.
Methods: We retrospectively reviewed the medical records of extragonadal germ cell 
tumor patients treated at Severance hospital, department of pediatrics or division of 
pediatric hematology-oncology over the last ten years.
Results: A total of 95 patients with extragonadal germ cell tumors were included in 
this study. Karyotyping was done in eight patients out of 95 patients, three patients 
with KS and one patient with Down syndrome. Twelve of extragonadal GCT patients 
presented at mediastinum, with most common histology of mature teratoma, and 
three patients presented with chromosomal abnormalities, two with KS and one with 
Down syndrome. A total of nine patients were diagnosed with retroperitoneal GCTs 
and only one had KS.
Conclusion: We described the characteristics of 95 cases of extragonadal GCTs. 
Although the mechanism of extragonadal GCTs in KS is not clear, karyotyping in pe-
diatric and adolescent extragonadal GCT patients could be helpful in figuring out 
chromosomal abnormalities including KS and their roles in GCT pathophysiology, 
which can contribute to improve one’s health.
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Introduction
Klinefelter syndrome (KS) affects approximately 1 in 
600 males [1] and has been linked to an increased risk 
for developing extragonadal germ cell tumors (GCTs) [2], 
especially malignant mediastinal germ cell tumors [3]. 
Approximately 8% of male patients with primary media-
stinal GCTs have KS [4] and these patients having a sig-
nificantly higher incidence of mediastinal tumors com-
pared with non-KS-GCT cases [1].
The exact mechanism underlying the carcinogenesis of 
KS-GCTs is unknown, but several studies have found that 
a significant percentage of KS patients also have other 
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Table 1. Demographics of the extragonadal germ cell tumors 













Yolk sac tumor 21 (22.1%)
Mature teratoma 16 (16.8%)
Immature teratoma 8 (8.4%)
Malignant teratoma 1 (1.1%)
Choriocarcinoma 3 (3.2%)








Stomach and duodenum, cervix and vagina.
sex chromosomal disorders [5]. Nearly one-third of me-
diastinal GCT cases have KS and 44% of males with 
KS-GCTs are unaware they have KS. Thus, the Children’s 
Oncology Group recommends KS screening for pediatric 
and adolescent males who present with GCTs, partic-
ularly with mediastinal GCTs, to help with their clinical 
management [1].
Other case reports have noted a higher prevalence of 
GCTs in KS patients suggesting a link between KS and 
the development of both mediastinal GCTs and retro-
peritoneal GCTs. Several cases of chromosomal abnor-
malities including KS and Down syndrome have been re-
ported in patients with GCTs [6]. 
KS is commonly underdiagnosed because of its symp-
toms are highly variable that it cannot be easily detected 
by health professionals [7]. We evaluated patients diag-
nosed with extragonadal GCTs in an effort to uncover 
whether we had any patient with Klinefelter syndrome in 
these cases. Our study focused on extragonadal GCTs 
from Severance hospital where we found a total of three 
patients with KS in 8 patients who had karyotyping out 
of 95 patients over the last ten years. Two patients pre-
sented with mediastinal GCTs and the third presented 
with retroperitoneal GCT. There was also one case of a 
Down syndrome patient in extragonadal GCTs. Our re-
sults highlight the need for karyotyping in extragonadal 
GCT patients to improve clinical treatment strategies. 
Materials and Methods
We retrospectively reviewed the medical records of 
patients diagnosed with extragonadal GCTs in Severance 
hospital from January 2010 to December 2019. A total of 
95 patients under 19 years of age were selected for this 
study. Inclusion criteria included: 1) treated in the de-
partment of pediatrics or division of pediatric hematol-
ogy-oncology, 2) primary site of tumor was extragonadal, 
3) diagnosed with a germ cell tumor by pathology. The 
data are given as numbers, percentages or medians with 
their interquartile range.
This study was approved by the Severance Hospital’s 
Institutional Review Board, and the requirement for in-
formed consent was waived (IRB No. 4-2020-0141). 
Results
Table 1 describes the demographics of the study popu-
lation. Median age was 12 years with an interquartile 
range of 1 to 15.5 years. The most common location for 
the extragonadal GCTs was the brain, followed by lesions 
in the sacrococcyx. A total of twelve patients in this study 
had mediastinal GCTs and nine had retroperitoneal GCTs. 
Germinoma and yolk sac tumors were the most common 
pathological manifestations in this study. Karyotyping 
was done in only eight patients and four of them had 
normal karyotype.
A total of 6 out of twelve in mediastinal, and a total 
of 5 out of nine in retroperitoneal GCTs were mature ter-
atomas (Table 2). For the mediastinal GCTs, yolk sac tu-
mors were the dominant pathology with most of the re-
maining tumors being classified as mature teratomas or 
immature teratomas. For the retroperitoneal GCTs, the 
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Table 2. Characteristics of the Mediastinal and Retroperitoneal 





Sex (M/F) 9/3 4/5





Yolk sac tumor 4 (33.3%) 1 (11.1%)
Mature teratoma 6 (50%) 5 (55.6%)
Immature teratoma 1 (8.3%) 2 (22.2%)
Embryonal carcinoma - 1 (11.1%)
Seminoma 1 (8.3%) -
Treatment
Surgery only 7 (58.3%) 4 (44.4%)
Surgery with chemotherapy 5 (41.7%) 5 (55.6%)
Karyotyping 4 1





Age is described as median and [interquartile range]. 
b)
Down 
syndrome was known before GCT diagnosis.
Fig. 1. Chest MRI (A) with heterogeneous enhancing mass at the
Rt. anterior mediastinum (white arrow), PET-CT (B) with increased
FDG uptake in the anterior mediastinal mass, suggesting malig-
nancy (black arrow).
treatment was divided into two categories: surgery only 
or surgery followed by chemotherapy. Patients with KS 
accounted for two out of twelve mediastinal GCTs, and 
one of the nine retroperitoneal GCTs. There was also a 
single case from the mediastinal GCTs described in a 17 
year old patient, with Down syndrome. This patient was 
treated with chemotherapy and has been in remission for 
two years. 
1) Case 1
A 16-year-old male whose height was 172.3 cm (50- 
75%) and weight was 83 kg (90-95%) presented with right 
shoulder and back pain over a seven-day period. Chest 
magnetic resonance imaging (MRI) at an outside hospital 
showed a well-defined heterogeneous enhancing mass at 
the right anterior mediastinum (Fig. 1A). Positron emis-
sion tomography-computed tomography (PET-CT) re-
vealed increased fludeoxyglucose (FDG) uptake in the 
anterior mediastinal mass (Fig. 1B). Bone marrow was 
then examined for staging and showed no signs of malig-
nancy, and his karyotype was consistent with Klinefelter 
syndrome (47, XXY). He also did sperm banking prior to 
chemotherapy, which showed azoospermia. The patient 
was unaware of his Klinefelter syndrome status before. 
Pathology of the mediastinal mass revealed a yolk sac tu-
mor with elevated alpha-fetoprotein (AFP) (8,170 ng/mL, 
normal range 0-9.0 ng/mL) levels. He was treated with 
four cycles of ifosfamide-carboplatin-etoposide (ICE) 
and bleomycin-cisplatin-etoposide (BEP) chemotherapy 
alternatively followed by mediastinal mass excision and 
then, followed up with another three cycles of chemo-
therapy using the same alternative chemotherapy regi-
men. Hormone tests were also done and showed that the 
patient’s sex hormones were within normal range. The 
patient has been tumor free for two years.
2) Case 2
A male baby who was born at full-term without any 
perinatal problems was diagnosed with Klinefelter syn-
drome (47, XXY) one month after birth by G-scanning, 
a test used to detect genetic or chromosomal abnormal-
ities using serum samples. There were no known chro-
mosomal abnormalities in his family. However, at seven 
months of age, a palpable abdominal mass was noted by 
chance, and abdomen pelvic CT completed at our hospital 
showed a large and lobulated mass, 15.3×8.7×13.6 cm 
(Fig. 2) in this abdomen. His height was 71.6 cm (50-75%) 
and weight was 10.4 kg (90-95%). His AFP level was 22.87 
ng/mL at diagnosis. He underwent excision of the in-
tra-abdominal mass, and its pathology revealed it to be 
a mature teratoma. He stayed normal in ultrasonography 
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Fig. 2. Abdomen-pelvic CT showing a large lobulated mass with
internal fat and calcification in the abdomen and pelvis (white 
arrow).
Fig. 3. Chest CT (A) showing a large
heterogeneous mass in the  anterior
mediastinum (white arrow), PET-CT
(B) with intense FDG uptake in the
anterior mediastinum, consistent with
malignancy (black arrow).
for 16 months after excision.
3) Case 3
A 16-year-old male had chest pain for 15 days, and 
underwent a chest CT, which showed a large hetero-
genous mass in the anterior mediastinum (Fig. 3A) and 
his PET-CT revealed intense FDG uptake in the anterior 
mediastinum (Fig 3B). Pathologic diagnosis in biopsy 
specimen was yolk sac tumor and initial AFP level at di-
agnosis was 26,663 ng/mL. He did not undergo bone 
marrow examination. He was referred to the urology de-
partment for sperm preservation prior to treatment. His 
height was 186 cm (＞97%) and weight was 68 kg (50- 
75%). His examination revealed small testis volume and 
azoospermia resulting in diagnosis of Klinefelter syn-
drome, which was confirmed by chromosomal analysis. 
After four cycle of ifosfamide-cisplatin-etoposide che-
motherapy, he had an operation to excise the tumor. For 
his follow up PET-CT revealed no evidence of recurrence 
or metastasis, he didn’t undergo adjuvant chemotherapy 
and has been tumor free for four years. 
Discussion
Pediatric germ cell tumors are a heterogeneous group 
of tumors identified based on histology, age at presen-
tation, tumor location and outcome [8]. It is known that 
GCTs represent approximately 3% of all pediatric can-
cers [9] and extragonadal sites account for 50% of GCTs, 
with sacroccygeal tumors being the most common [8]. 
Mediastinal GCTs are occasionally reported by case 
and malignant type represents only 4% of the mediastinal 
GCTs [10]. Yolk sac tumors and mixed histology are the 
predominant pathology for this type of tumor [11]. Cisplatin- 
based chemotherapy followed by surgical resection of 
residual disease is the first line treatment for GCTs in 
adults and children [9].
Nearly one-third of mediastinal tumors are diagnosed 
in males with KS and a majority of these cases occur in 
adolescents. Our first and third cases showed similar cha-
racteristics, as they were both adolescents, with media-
stinal yolk sac tumors who were diagnosed with KS after 
the mass was found. This supports the hypothesis that KS 
screening in pediatric and adolescent males with media-
stinal GCTs is important for proper clinical intervention 
[1].
Primary retroperitoneal germ cell tumors are also rare, 
accounting for approximately four percent of all GCTs 
[12]. Mature and immature teratomas are the most com-
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mon histopathology for this type of tumor, however ma-
lignant retroperitoneal GCTs tend to be yolk sac tumors 
[12]. Primary resection is preferred, but depending on 
the extent of disease, chemotherapy can be done before 
complete resection [8,12].
There have been occasional reports linking chromoso-
mal abnormalities with retroperitoneal GCTs [13,14]. Among 
the twelve cases in this report, chromosomal abnormal-
ities were observed in three cases: two with Down syn-
drome and one with KS. The majority of retroperitoneal 
GCTs are benign mature and immature teratomas, and 
ten of the twelve cases were diagnosed in the first year 
of life [6]. Our second case showed similar characteristics 
to these in terms of age at diagnosis, histology type and 
chromosomal anomaly.
Severance hospital had twelve cases of mediastinal 
GCTs and nine retroperitoneal patients within the last 
ten years (from January 2010 to December 2019). There 
were four patients in the mediastinal GCTs who did kar-
yotyping and among them, three patients with chromo-
somal abnormalities: two with KS and one with Down 
syndrome. For the retroperitoneal GCTs, only one pa-
tient underwent karyotyping and was diagnosed with KS. 
This is not a representation of the incidence of chro-
mosomal abnormalities in the extragonadal GCT cases 
from this hospital as most patients did not perform kar-
yotyping, for only eight out of 95 patients did karyotyp-
ing in this study. Though, they might be less likely to 
have chromosomal abnormalities because patients have 
been followed up for several years, some patients with 
the department of pediatric endocrinology, which makes 
it enable to detect signs and symptoms of chromosomal 
abnormalities.
The carcinogenic mechanism of GCTs is unknown, but 
genes on the extra X chromosome which escape in-
activation may contribute to the KS phenotype and in-
crease the risk of GCT development [1] as testicular tu-
mors in patients with an additional X chromosome have 
been shown to have an increased expression of several 
oncogenes [15]. However, it will require further study to 
understand why extragonadal GCTs show a preference 
for the mediastinum [4].
Although the relationship between KS and extragonadal 
GCTs and its underlying pathological mechanisms are 
not yet clear, karyotyping for pediatric and adolescent 
extragonadal GCT patients, especially those in the me-
diastinum, could be helpful in identifying the chromoso-
mal abnormalities in these patients and could help in the 
management of any comorbidities they may present with. 
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